IQVIA™ Real-World Insights Bibliography

Cost-utility model for 2nd generation treatment of chronic HCV in general population: impact of EASL recommendations in 2016 and 2018
Author(s): Nat?lia Pascual-Argent? (1,2); Carlos Crespo (1,3); Laura Planellas (4); M?riam Solozabal (4), N?ria Perulero (4); Jaume Puig-Junoy (1,2)
Affiliations(s): (1) UPF Barcelona School of Management; (2) Dept. Econom?a y Empresa ? CRES UPF; (3) Universitat de Barcelona; (4) HEOR-RWE, IQVIA Spain
Publication(s):  XXXIX Jornadas de Econom?a de la Salud. Albacete, 12 al 14 de junio de 2019
Document Type(s): Poster,
Countries: Spain,
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Health economics, Infectious disease,
2019
  L:
A:
Spanish
Clinical setting: hospital, Cost effectiveness,
  Add to report
 
 
LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION.
Author(s): Allou A*, Carette J*, Minacori R*, Touahmia S*, Bourguignon S*, Troubat A*, Maurel F*
Affiliations(s): IQVIA France - RWI
Publication(s):  ISPOR 2018
Document Type(s): Poster,
Countries: France,
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Health economics, Hematology,
2018
  L:
A:
English
Cost effectiveness, Market impact, Review,
  Add to report
 
 
WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE.
Author(s): Moutier Hélène; Bourguignon Sandrine; Maurel Frédérique; Bodaghi Charles
Affiliations(s): RWI IQVIA France
Publication(s):  ISPOR 2018
Document Type(s): Poster,
Countries: France,
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases,
2018
  L:
A:
English
Cost effectiveness, Pricing & Reimbursement, Willingness to pay,
  Add to report
 
 
ASSESSMENT OF THE UNIT COSTS IN IMAGING ACTS: THE EXAMPLE OF MRI AND CT-SCAN ACTS IN France
Author(s): Vasilescu L., Faller M., Allou A.
Affiliations(s): IQVIA France - RWI
Publication(s):  ISPOR 2018
Document Type(s): Poster,
Countries: France,
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Methodology,
2018
  L:
A:
English
Literature Review, Public Health, Review,
  Add to report
 
 
A COST-EFFECTIVENESS ANALYSIS COMPARING THE ORIGINATOR RECOMBINANT HUMAN ALFA TO THEIR BIOSIMILARS FOLLITROPIN ALFA FOR THE TREATMENT OF INFERTILITY.
Author(s): Ravonimbola H(1), Petrica N (1), Maurel F(1), Murphy C(2), Doré C(2), Fresneau L(2),
Affiliations(s): (1) QuintilesIMS, Paris France (2) Merck Serono, France
Publication(s):  ISPOR 2017
Document Type(s): Poster,
Countries: France,
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2017
  L:
A:
English
Cost effectiveness, Literature Review, Randomised controlled trial,
  Add to report
 
 
HEALTH-ECONOMICS EVALUATIONS IN FRANCE, ENGLAND, CANADA AND AUTRALIA: COMPARISON OF METHODOLOGIES AND IMPACT ON DRUGS
Author(s): Bucher D*, Abalan M-E*, Allou A*, Dumon L*, Vialard L *, Troubat A*, Maurel F*
Affiliations(s): IQVIA France - RWI
Publication(s):  ISPOR 2017
Document Type(s): Poster,
Countries: Australia, Canada, France, UK,
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2017
  L:
A:
English
Cost effectiveness, Literature Review, Pricing & Reimbursement, Review,
  Add to report
 
 
RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma.
Author(s): Coleman AL1,2, Lum FC1, Velentgas P3, Campion D3, Su Z3, Gliklich RE4; RiGOR Study Group.
Affiliations(s): 1H. Dunbar Hoskins Jr, MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA. 2Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. 3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA.
Publication(s):  Journal of Comparative Effectiveness. Jan 2016; 5(1), 65-78
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
Observational study, Prospective study, RWLPR (Real-World Late Phase Research-quintiles,
  Add to report
 
 
Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
Author(s): Coleman AL1,2, Lum FC2, Velentgas P3, Su Z3, Gliklich RE4; RiGOR Study Group.
Affiliations(s): 1Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. 2H Dunbar Hoskins, Jr MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA. 3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA. 4Massachusetts Eye & Ear & Harvard Medical School, Boston, MA 02114, USA.
Publication(s):  J Comp Eff Res. 2016 Jan;5(1):87-98
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
Observational study, Prospective study,
  Add to report
 
 
Quality of life and visual acuity outcomes in the RiGOR study
Author(s): Coleman AL1,2, Lum FC1, Gliklich RE3, Velentgas P4, Su Z4; RiGOR Study Group.
Affiliations(s): 1H Dunbar Hoskins, Jr MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA. 2Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. 3Massachusetts Eye & Ear Infirmary & Harvard Medical School, Boston, MA 02114, USA. 4Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, 201 Broadway #5, Cambridge, MA 02139, USA.
Publication(s):  J Comp Eff Res. 2016 Jan;5(1):99-111.
Document Type(s): Article,
Countries: 
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
Observational study, Prospective study,
  Add to report
 
 
Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study.
Author(s): Coleman AL1,2, Lum FC2, Velentgas P3, Su Z3, Gliklich RE4; RiGOR Study Group.
Affiliations(s): 1Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. 2H Dunbar Hoskins Jr, MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA. 3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA, 02139. 4Massachusetts Eye & Ear Infirmary & Harvard Medical School, Boston, MA 02114, USA
Publication(s):  J Comp Eff Res. 2016 Jan;5(1):79-85.
Document Type(s): Article,
Countries: 
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
Observational study, Prospective study,
  Add to report
 
 
 1 of 4 Next Page Last Page